Suzuki Atsushi    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position   Assistant Professor
Language	English
Title	Outcome of Severe Ischemic Heart Failure Patients Treated with Amiodarone
Conference	The 21st Annual Scientific Meeting of the Japanese Heart Failure Society
Promoters	Japanese Heart Failure Society
Conference Type	Nationwide Conferences
Presentation Type	Poster notice
Lecture Type	General
Publisher and common publisher	◎SUZUKI Atsushi, SHIGA Tsuyoshi, ARAI Kotaro, HAGIWARA Nobuhisa
Date	2017/10/13
Venue (city and name of the country)	Akita, JAPAN
Summary	Severe heart failure patients with reduced left ventricular ejection fraction (LVEF) still have poor outcomes. The outcome of amiodarone treatment for severe ischemic HF patients is still unknown. We studied 65 patients (67 ± 12 years old, 54 men) with severe HF (New York Heart Association [NYHA] functional class 3 or 4) due to ischemic heart disease treated by amiodarone. During 24 months of follow-up, 44 patients (81%) were died (Fig. 1). 89% of patients were treated with beta-blockers and/or angiotensinconverting-enzyme inhibitors or angiotensin-receptor blockers. After amiodarone treatment, NYHA functional class was significantly improved, and heart rate was significantly decreased than before (Table 1). However, LVEF was not improved. Alternative treatment for severe heart failure patients is needed.